This sponsored webinar will assist population-based decision makers with enhancing their understanding of Eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) and support appropriate medical management for patients with these disorders.
Value-based contracts often require significant time to reach final negotiation and implementation. Disconnect, misalignment, and lack of a common framework for value-based purchasing agreements has exacerbated these challenges. This slide deck provides a unified language for discussing and designing value-based contracts across payers, provider systems, and manufacturers.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
During AMCP 2022 in March, Dr. Kali Cyrus lead a workshop titled: A Primer on Bias from Discovery to Implementing Strategies to Address. AMCP CEO, Susan Cantrell explores the highlights from this workshop and how managed care professionals may be able to implement Dr. Cyrus' strategies in their day-to-day.
July 2022 Legislative & Regulatory Briefing; AMCP Publishes Position Statement on Addressing Racial Health Disparities; [Blog] The Pre-approval Information Exchange Act of 2022 Passes in the House; How the U.S.’s Pending PIE Act Will Improve Patient’s Access to Medication; FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations; HHS Issues Guidance to Retail Pharmacies Clarifying Their Obligations to Ensure Access to Reproductive Health Care Services.
AMCP supports the use of preferred pharmacy networks as a way of providing additional options to incentivize higher quality care and improve cost-effectiveness.